 |
PDBsum entry 1vvd
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Complement inhibitor
|
PDB id
|
|
|
|
1vvd
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
272:253-265
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
NMR studies of a viral protein that mimics the regulators of complement activation.
|
|
A.P.Wiles,
G.Shaw,
J.Bright,
A.Perczel,
I.D.Campbell,
P.N.Barlow.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Vaccinia virus complement control protein (VCP) is a 243-residue protein that is
similar in sequence to the regulators of complement activation; its role is to
defend the virus against attack by the host complement system. A fragment of
this protein spanning the two complement protein (CP)-modules (residues 126 to
243) which make up the C-terminal half of VCP has been expressed in Pichia
pastoris. A 15N-labelled sample was purified for the purposes of structure
determination and measurements of dynamics in solution using NMR. Structures
were calculated on the basis of 1767 NMR-derived distance and angle restraints,
with a longer than normal high-temperature simulated annealing (SA) protocol
which improved convergence. The viral CP-modules are structurally very similar
to the 15th and 16th CP-modules of human factor H (fH; average r.m.s.d., for
invariant Trp and Cys, four pair-wise comparisons,=1.2 A) but less similar to
the fifth CP-module of fH (average r.m.s.d.=2.2 A). In the VCP fragment, the
orientation of one module with respect to the other is clearly defined by the
experimental data, and T1 measurements are consistent with only limited
flexibility at the module-module interface. The r.m.s.d. over all of the 118
residues (backbone atoms) is 0.73 A. The intermodular orientation is better
defined than, and significantly different from, that observed in a CP-module
pair from fH (re-calculated using the extended SA protocol). In VCP the long
axis of the second module is tilted by 59(+/-4) degrees with respect to the
first module (50(+/-13) degrees in the fH pair), and twisted with respect to the
first module by 22(+/-6) degrees (223(+/-17) degrees in fH). The differences
between the human and viral proteins may be rationalised in terms of the lack of
hydrogen-bond stabilised secondary structure in the N-terminal portion of fH
module 16, and the number and type of amino acid side-chains which make up the
interface. A similar intermodular interface may be predicted between the third
and fourth module of human C4 binding protein and, probably, between the third
and fourth modules of the guinea pig acrosomal matrix protein 67; but the
formulation of general rules for predicting the structure of interfaces between
CP-modules awaits further experimental data.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 7.
Figure 7. Topological similarity amongst members of
the CP-module family. An overlay of all five CP-mod-
ules for which detailed tertiary structures are now avail-
able (all overlaid on fH15 using the alpha and beta
carbon atoms of the invariant Trp and Cys residues).
The backbones are shown as ribbons. The left-hand dia-
gram emphasises the backbone (thick ribbon); the right-
hand diagram shows the overlay of invariant Trp and
Cys residues (stick representation). Key: red, H5;
magenta, H15; yellow, H16; cyan, VCP3; white, VCP4.
|
 |
Figure 8.
Figure 8. A comparison of human and viral proteins.
A MOLSCRIPT (Kraulis, 1991) representation of the two
CP-module pairs for which three-dimensional structures
are now available. Refined and minimised average
structures are shown. The tryptophan residues are
shown as a CPK surface.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1997,
272,
253-265)
copyright 1997.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Láng,
K.Szilágyi,
B.Major,
P.Gál,
P.Závodszky,
and
A.Perczel
(2010).
Intermodule cooperativity in the structure and dynamics of consecutive complement control modules in human C1r: structural biology.
|
| |
FEBS J,
277,
3986-3998.
|
 |
|
|
|
|
 |
K.Van Vliet,
M.R.Mohamed,
L.Zhang,
N.Y.Villa,
S.J.Werden,
J.Liu,
and
G.McFadden
(2009).
Poxvirus proteomics and virus-host protein interactions.
|
| |
Microbiol Mol Biol Rev,
73,
730-749.
|
 |
|
|
|
|
 |
S.Vucetic,
H.Xie,
L.M.Iakoucheva,
C.J.Oldfield,
A.K.Dunker,
Z.Obradovic,
and
V.N.Uversky
(2007).
Functional anthology of intrinsic disorder. 2. Cellular components, domains, technical terms, developmental processes, and coding sequence diversities correlated with long disordered regions.
|
| |
J Proteome Res,
6,
1899-1916.
|
 |
|
|
|
|
 |
L.Zhang,
and
D.Morikis
(2006).
Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics.
|
| |
Biophys J,
90,
3106-3119.
|
 |
|
|
|
|
 |
E.Ciulla,
A.Emery,
D.Konz,
and
J.Krushkal
(2005).
Evolutionary history of orthopoxvirus proteins similar to human complement regulators.
|
| |
Gene,
355,
40-47.
|
 |
|
|
|
|
 |
J.White,
P.Lukacik,
D.Esser,
M.Steward,
N.Giddings,
J.R.Bright,
S.J.Fritchley,
B.P.Morgan,
S.M.Lea,
G.P.Smith,
and
R.A.Smith
(2004).
Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli.
|
| |
Protein Sci,
13,
2406-2415.
|
 |
|
|
|
|
 |
R.J.Abbott,
V.Knott,
P.Roversi,
S.Neudeck,
P.Lukacik,
P.A.Handford,
and
S.M.Lea
(2004).
Crystallization and preliminary X-ray diffraction analysis of three EGF domains of EMR2, a 7TM immune-system molecule.
|
| |
Acta Crystallogr D Biol Crystallogr,
60,
936-938.
|
 |
|
|
|
|
 |
S.Blein,
R.Ginham,
D.Uhrin,
B.O.Smith,
D.C.Soares,
S.Veltel,
R.A.McIlhinney,
J.H.White,
and
P.N.Barlow
(2004).
Structural analysis of the complement control protein (CCP) modules of GABA(B) receptor 1a: only one of the two CCP modules is compactly folded.
|
| |
J Biol Chem,
279,
48292-48306.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
V.K.Ganesh,
S.A.Smith,
G.J.Kotwal,
and
K.H.Murthy
(2004).
Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.
|
| |
Proc Natl Acad Sci U S A,
101,
8924-8929.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Feinberg,
J.C.Uitdehaag,
J.M.Davies,
R.Wallis,
K.Drickamer,
and
W.I.Weis
(2003).
Crystal structure of the CUB1-EGF-CUB2 region of mannose-binding protein associated serine protease-2.
|
| |
EMBO J,
22,
2348-2359.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Bernet,
J.Mullick,
A.K.Singh,
and
A.Sahu
(2003).
Viral mimicry of the complement system.
|
| |
J Biosci,
28,
249-264.
|
 |
|
|
|
|
 |
J.Mullick,
A.Kadam,
and
A.Sahu
(2003).
Herpes and pox viral complement control proteins: 'the mask of self'.
|
| |
Trends Immunol,
24,
500-507.
|
 |
|
|
|
|
 |
M.Wingens,
T.Walma,
H.van Ingen,
C.Stortelers,
J.E.van Leeuwen,
E.J.van Zoelen,
and
G.W.Vuister
(2003).
Structural analysis of an epidermal growth factor/transforming growth factor-alpha chimera with unique ErbB binding specificity.
|
| |
J Biol Chem,
278,
39114-39123.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Jha,
and
G.J.Kotwal
(2003).
Vaccinia complement control protein: multi-functional protein and a potential wonder drug.
|
| |
J Biosci,
28,
265-271.
|
 |
|
|
|
|
 |
B.O.Smith,
R.L.Mallin,
M.Krych-Goldberg,
X.Wang,
R.E.Hauhart,
K.Bromek,
D.Uhrin,
J.P.Atkinson,
and
P.N.Barlow
(2002).
Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor.
|
| |
Cell,
108,
769-780.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Budayova-Spano,
M.Lacroix,
N.M.Thielens,
G.J.Arlaud,
J.C.Fontecilla-Camps,
and
C.Gaboriaud
(2002).
The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex.
|
| |
EMBO J,
21,
231-239.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.J.Hasan,
E.Pawelczyk,
P.T.Urvil,
M.S.Venkatarajan,
P.Goluszko,
J.Kur,
R.Selvarangan,
S.Nowicki,
W.A.Braun,
and
B.J.Nowicki
(2002).
Structure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation.
|
| |
Infect Immun,
70,
4485-4493.
|
 |
|
|
|
|
 |
G.Szakonyi,
J.M.Guthridge,
D.Li,
K.Young,
V.M.Holers,
and
X.S.Chen
(2001).
Structure of complement receptor 2 in complex with its C3d ligand.
|
| |
Science,
292,
1725-1728.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Schwalbe,
S.B.Grimshaw,
A.Spencer,
M.Buck,
J.Boyd,
C.M.Dobson,
C.Redfield,
and
L.J.Smith
(2001).
A refined solution structure of hen lysozyme determined using residual dipolar coupling data.
|
| |
Protein Sci,
10,
677-688.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.H.Murthy,
S.A.Smith,
V.K.Ganesh,
K.W.Judge,
N.Mullin,
P.N.Barlow,
C.M.Ogata,
and
G.J.Kotwal
(2001).
Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans.
|
| |
Cell,
104,
301-311.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Gaboriaud,
V.Rossi,
I.Bally,
G.J.Arlaud,
and
J.C.Fontecilla-Camps
(2000).
Crystal structure of the catalytic domain of human complement c1s: a serine protease with a handle.
|
| |
EMBO J,
19,
1755-1765.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Hourcade,
M.K.Liszewski,
M.Krych-Goldberg,
and
J.P.Atkinson
(2000).
Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.
|
| |
Immunopharmacology,
49,
103-116.
|
 |
|
|
|
|
 |
J.L.Cereghino,
and
J.M.Cregg
(2000).
Heterologous protein expression in the methylotrophic yeast Pichia pastoris.
|
| |
FEMS Microbiol Rev,
24,
45-66.
|
 |
|
|
|
|
 |
L.Spendlove,
L.Li,
V.Potter,
D.Christiansen,
B.E.Loveland,
and
L.G.Durrant
(2000).
A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions.
|
| |
Eur J Immunol,
30,
2944-2953.
|
 |
|
|
|
|
 |
S.A.Smith,
N.P.Mullin,
J.Parkinson,
S.N.Shchelkunov,
A.V.Totmenin,
V.N.Loparev,
R.Srisatjaluk,
D.N.Reynolds,
K.L.Keeling,
D.E.Justus,
P.N.Barlow,
and
G.J.Kotwal
(2000).
Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense.
|
| |
J Virol,
74,
5659-5666.
|
 |
|
|
|
|
 |
A.E.Oran,
and
D.E.Isenman
(1999).
Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35).
|
| |
J Biol Chem,
274,
5120-5130.
|
 |
|
|
|
|
 |
A.M.Blom,
J.Webb,
B.O.Villoutreix,
and
B.Dahlbäck
(1999).
A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function.
|
| |
J Biol Chem,
274,
19237-19245.
|
 |
|
|
|
|
 |
B.Bouma,
P.G.de Groot,
J.M.van den Elsen,
R.B.Ravelli,
A.Schouten,
M.J.Simmelink,
R.H.Derksen,
J.Kroon,
and
P.Gros
(1999).
Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure.
|
| |
EMBO J,
18,
5166-5174.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Mossakowska,
I.Dodd,
W.Pindar,
and
R.A.Smith
(1999).
Structure-activity relationships within the N-terminal short consensus repeats (SCR) of human CR1 (C3b/C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation.
|
| |
Eur J Immunol,
29,
1955-1965.
|
 |
|
|
|
|
 |
J.M.Casasnovas,
M.Larvie,
and
T.Stehle
(1999).
Crystal structure of two CD46 domains reveals an extended measles virus-binding surface.
|
| |
EMBO J,
18,
2911-2922.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Evenäs,
P.García De Frutos,
S.Linse,
and
B.Dahlbäck
(1999).
Both G-type domains of protein S are required for the high-affinity interaction with C4b-binding protein.
|
| |
Eur J Biochem,
266,
935-942.
|
 |
|
|
|
|
 |
R.Schwarzenbacher,
K.Zeth,
K.Diederichs,
A.Gries,
G.M.Kostner,
P.Laggner,
and
R.Prassl
(1999).
Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome.
|
| |
EMBO J,
18,
6228-6239.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Lea,
R.Powell,
and
D.Evans
(1999).
Crystallization and preliminary X-ray diffraction analysis of a biologically active fragment of CD55.
|
| |
Acta Crystallogr D Biol Crystallogr,
55,
1198-1200.
|
 |
|
|
|
|
 |
T.Galvez,
M.L.Parmentier,
C.Joly,
B.Malitschek,
K.Kaupmann,
R.Kuhn,
H.Bittiger,
W.Froestl,
B.Bettler,
and
J.P.Pin
(1999).
Mutagenesis and modeling of the GABAB receptor extracellular domain support a venus flytrap mechanism for ligand binding.
|
| |
J Biol Chem,
274,
13362-13369.
|
 |
|
|
|
|
 |
I.D.Campbell,
and
A.K.Downing
(1998).
NMR of modular proteins.
|
| |
Nat Struct Biol,
5,
496-499.
|
 |
|
|
|
|
 |
M.Krych,
R.Hauhart,
and
J.P.Atkinson
(1998).
Structure-function analysis of the active sites of complement receptor type 1.
|
| |
J Biol Chem,
273,
8623-8629.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |